I believe we will get UK or EU approval first. Cognate Manufacturing in UK and Germany and NWBO operations at Sawston up first. From Cognate website: "This (Memphis) facility supported technology transfer and external manufacturing in close collaboration with partner facilities in Germany and England." Longshot to get FDA first, IMO. Unfortunately, NWBO is not going to lock data or talk about SAP until they are comfortable with FDA comments and path forward. Doubtful it happens this year, but I hope I am wrong. If some trials start, that would be the most I expect this year. I don't even think they will be presenting anything "new" at any conference this quarter.